Bottom line
How much do FPHAX and FSPHX overlap?
33% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 55.8% of FPHAX's assets and 23.3% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
FSPHX holds far more positions (152 vs 57), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FPHAX and FSPHX have in common
| Holding | % of FPHAX | % of FSPHX | Overlap |
|---|---|---|---|
| ELI LILLY and CO | 28.78% | 8.03% | 8.03% |
| Viatris Inc | 5.45% | 1.20% | 1.20% |
| Ucb Sa | 5.09% | 2.03% | 2.03% |
| MERCK and CO INC | 4.74% | 1.60% | 1.60% |
| Gilead Sciences Inc | 3.97% | 2.21% | 2.21% |
| JOHNSON and JOHNSON | 3.77% | 4.91% | 3.77% |
| Fidelity Revere Street Trust | 2.44% | 2.17% | 2.17% |
| Moderna Inc | 1.57% | 1.18% | 1.18% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FPHAX
- Gsk Plc — 8.17%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
- Royalty Pharma Plc — 2.67%
- Intellia Therapeutics Inc — 1.19%
- Beam Therapeutics Inc — 1.10%
- Axsome Therapeutics Inc — 1.08%
- Biontech Se — 1.04%
- Xenon Pharmaceuticals Inc — 0.82%
- Ocular Therapeutix Inc — 0.80%
- Idexx Laboratories Inc — 0.61%
- Swedish Orphan Biovitrum Ab — 0.54%
Only in FSPHX
- Danaher Corp — 6.89%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Abbvie Inc — 2.03%
- Bio Techne Corp — 1.70%
- Argenx Se — 1.56%
- Cvs Health Corp — 1.29%
- Nuvalent Inc — 1.28%
- Natera Inc — 1.27%
- Brightspring Health Services Inc — 1.23%
- Cencora Inc — 1.14%
- West Pharmaceutical Svcs Inc — 1.12%
Asset mix
| Asset type | FPHAX | FSPHX |
|---|---|---|
| Stocks | 98.7% | 97.7% |
| Cash & short-term funds | 2.6% | 2.4% |
| Preferred stock | 0.7% | 2.0% |
| Bonds | 0.1% | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | FPHAX | FSPHX |
|---|---|---|
| US | 64.8% | 87.0% |
| GB | 15.1% | 2.1% |
| BE | 5.3% | 2.0% |
| CH | 4.5% | 1.4% |
| KY | 4.5% | 1.4% |
| IE | 4.1% | 1.0% |
| NL | 0.3% | 2.4% |
| DK | 0.3% | 2.2% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FPHAX and FSPHX overlap?
What stocks do FPHAX and FSPHX have in common?
Should I own both FPHAX and FSPHX?
Which holds more stocks, FPHAX or FSPHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.